Treating Dual Nicotine Users with Smoking Cessation Therapy

Jul.22.2022
A study from the University of Washington Medicine found that tobacco treatment can help dual smokers quit smoking.

Researchers at the University of Washington School of Medicine, led by Louis, have found that as smokers attempt to quit smoking, some turn to e-cigarettes. However, these individuals often become dual nicotine users, simultaneously smoking traditional cigarettes and e-cigarettes. The good news is that researchers have found that smoking cessation treatments that focus on nicotine replacement and counseling can help these dual users quit smoking.


The majority of the 40 million smokers in the United States admit to wanting to quit smoking. Some are turning to e-cigarettes as a step towards that goal. However, an increasing number of people are becoming dual nicotine users, smoking both traditional cigarettes and e-cigarettes.


Researchers have found that many people who try to quit smoking end up increasing their intake of nicotine instead. However, there is good news: a smoking cessation treatment that focuses on nicotine replacement and counseling, which has been approved by the US Food and Drug Administration (FDA), can help dual users quit smoking. In fact, this treatment appears to be effective for both dual users and those who only smoke traditional cigarettes.


The research findings were published in the "Thorax" journal on July 21st.


We suggest FDA-approved treatment methods such as nicotine replacement therapy, medication such as varenicline, and counseling for smokers. However, we are aware that an increasing number of people are using both cigarettes and e-cigarettes. The good news is that tobacco treatment can still help these individuals quit smoking and overcome their nicotine addiction." - Dr. Xunchen Li, Medical Doctor and Senior Researcher and Associate Professor in Psychiatry.


On average, about 70% of smokers attempt to quit smoking. Another 20% claim they want to smoke less. However, among those who have not received any treatment such as nicotine replacement therapy or counseling, only about 5% successfully quit smoking.


A review of the electronic health records of over 110,000 smokers who visited Barnes Jewish Hospital between 2018 and 2020 found that the number of electronic cigarette users had doubled. While some individuals may have started using e-cigarettes as a potential step towards quitting smoking, many seem to have become trapped. Rather than quitting, they began using electronic cigarettes while continuing to smoke traditional cigarettes.


In the course of the research, a growing number of relatively small but dual users of smoking were identified. Approximately 0.8% of individuals reported dual smoking in the first year of the study, but by the end of the data collection process, this figure had increased to 2.3%. The authors note that the actual number of dual users may be higher.


Researchers have discovered that around one in five (20.8%) dual users quit smoking within 12 months. In comparison, the quit rate for those who only smoke traditional cigarettes is 16.8%.


Treatment appears to still be the key for dual users. When they receive smoking cessation therapy, nearly one-third (29%) become non-smokers after 12 months. Among dual users who do not receive treatment, only about 17% are able to quit.


The first author, Dr. Brendan T., who is a surgical resident and thoracic surgery researcher, stated that although dual users have a higher quit rate, approximately two-thirds of individuals still smoke a year later, even after treatment. Additionally, due to limited knowledge regarding the long-term health effects of e-cigarette use, he advises against using e-cigarettes as a means to quit smoking.


Hayden stated that the current scientific consensus is that using both traditional cigarettes and e-cigarettes is detrimental to one's health. Although current guidelines do not recommend using e-cigarettes as a way to quit smoking, it has been found that among those who use both products, traditional tobacco treatments approved by the FDA, such as nicotine replacement therapy and behavioral support therapy, can help them quit smoking.


I apologize, but without context or specific text to work with, I am unable to complete this task. Please provide me with more information or a specific text that needs translation.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.
Nov.04
Latvia’s Constitutional Court Upholds Vape Flavor Ban as Constitutional
Latvia’s Constitutional Court Upholds Vape Flavor Ban as Constitutional
The Constitutional Court of Latvia upheld the 2025 vape-flavor ban as constitutional, rejecting appeals by Pro Vape and SIA MASS Industry. Judges said the restrictions serve a legitimate public-health purpose by protecting youth from nicotine addiction and that the social benefits outweigh business losses.
Oct.24 by 2FIRSTS.ai
California DOJ Outlines Next Steps for Unflavored Tobacco List; Enforcement to Target “Obviously Flavored” Products
California DOJ Outlines Next Steps for Unflavored Tobacco List; Enforcement to Target “Obviously Flavored” Products
The California DOJ issued Information Bulletin No. 2025-DLE-17 on November 10, 2025, providing an update on the state’s flavored tobacco enforcement. The Attorney General’s office is set to launch the Unflavored Tobacco List (UTL) by December 31, 2025, identifying tobacco products without characterizing flavors that may legally be sold in California. Enforcement will continue to focus on “obviously flavored” products, while unregistered products remain subject to seizure and penalties.
Nov.17 by 2FIRSTS.ai
PMI Japan Upgrades IQOS ILUMA i One with New Button Layout, Aluminum Base
PMI Japan Upgrades IQOS ILUMA i One with New Button Layout, Aluminum Base
PMI Japan has refreshed its all-in-one heated tobacco device, IQOS ILUMA i One, with upgraded materials and exterior design. Sales begin October 29 via IQOS stores and the official website. The new model retains core features such as auto-start and continuous use, but is not compatible with accessories from the previous version.
Oct.30 by 2FIRSTS.ai
Ireland Considering Ban on Nicotine Pouches to Protect Youth, Says Chief Medical Officer
Ireland Considering Ban on Nicotine Pouches to Protect Youth, Says Chief Medical Officer
Ireland’s Department of Health is examining a ban on nicotine pouches to curb nicotine use among young people. Chief Medical Officer Prof. Mary Horgan said the ban could be included in amendments to the current tobacco bill.
Nov.10 by 2FIRSTS.ai
Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.
Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.
E-cigarette brand SKE has listed its “30K Pro Max” bundle across multiple UK e-commerce platforms. The 2-in-1 device features dual flavors with a twist-to-switch design, draw activation, and mesh heating, with a claimed total of up to 30,000 puffs. Across several channels, single-unit pricing ranges from about £8.99 to £10.99.
Oct.24 by 2FIRSTS.ai